BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20167306)

  • 1. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy.
    Aghotor J; Pfueller U; Moritz S; Weisbrod M; Roesch-Ely D
    J Behav Ther Exp Psychiatry; 2010 Sep; 41(3):207-11. PubMed ID: 20167306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
    Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
    Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for the efficacy of a metacognitive group training in schizophrenia.
    Moritz S; Kerstan A; Veckenstedt R; Randjbar S; Vitzthum F; Schmidt C; Heise M; Woodward TS
    Behav Res Ther; 2011 Mar; 49(3):151-7. PubMed ID: 21276962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia.
    Moritz S; Vitzthum F; Randjbar S; Veckenstedt R; Woodward TS
    Curr Opin Psychiatry; 2010 Nov; 23(6):561-9. PubMed ID: 20683332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention.
    Moritz S; Woodward TS
    Curr Opin Psychiatry; 2007 Nov; 20(6):619-25. PubMed ID: 17921766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms.
    Vitzthum FB; Veckenstedt R; Moritz S
    Behav Cogn Psychother; 2014 Jan; 42(1):105-10. PubMed ID: 23631928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia.
    Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D
    Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders.
    Lam KC; Ho CP; Wa JC; Chan SM; Yam KK; Yeung OS; Wong WC; Balzan RP
    Behav Res Ther; 2015 Jan; 64():38-42. PubMed ID: 25513971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia.
    Moritz S; Andreou C; Schneider BC; Wittekind CE; Menon M; Balzan RP; Woodward TS
    Clin Psychol Rev; 2014 Jun; 34(4):358-66. PubMed ID: 24866025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of metacognitive training for patients with schizophrenia: a narrative systematic review of studies published between 2009 and 2015.
    Pankowski D; Kowalski J; Gawęda Ł
    Psychiatr Pol; 2016; 50(4):787-803. PubMed ID: 27847929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme.
    Balzan RP; Delfabbro PH; Galletly CA; Woodward TS
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1126-36. PubMed ID: 24159051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: a feasibility study.
    Morrison AP; Pyle M; Chapman N; French P; Parker SK; Wells A
    J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):280-4. PubMed ID: 24440585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial.
    van Oosterhout B; Krabbendam L; de Boer K; Ferwerda J; van der Helm M; Stant AD; van der Gaag M
    Psychol Med; 2014 Oct; 44(14):3025-35. PubMed ID: 25066223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia.
    Gawęda Ł; Krężołek M; Olbryś J; Turska A; Kokoszka A
    J Behav Ther Exp Psychiatry; 2015 Sep; 48():98-104. PubMed ID: 25775947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different sides of the same coin? Intercorrelations of cognitive biases in schizophrenia.
    Moritz S; Veckenstedt R; Hottenrott B; Woodward TS; Randjbar S; Lincoln TM
    Cogn Neuropsychiatry; 2010 Jul; 15(4):406-21. PubMed ID: 20146127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transportability and feasibility of Social Cognition And Interaction Training (SCIT) in community settings.
    Roberts DL; Penn DL; Labate D; Margolis SA; Sterne A
    Behav Cogn Psychother; 2010 Jan; 38(1):35-47. PubMed ID: 19857363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
    Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
    Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.